National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
What’s the deal with off-label use of Mounjaro?
With supply shortages of other diabetes therapies persisting, off-label prescribing of Mounjaro for weight loss has become more common.
Pharmacy and medical termination of pregnancy
One in six Australian pharmacists are pro-life and oppose elective termination of pregnancy. But this does not diminish their responsibilities to patients.
Marie enters your...
Cautionary advisory labels
Scenario
A 70-year-old male patient is being discharged from hospital today and you note that swallowing difficulties are detailed in his case history. The dispensing...
Changes to S3 salbutamol scheduling
Amendments to the S3 listing for salbutamol released last week will ease dispensing restrictions, hopefully reducing patient frustration and stopping unacceptable abuse experienced by some pharmacists.
High concentration topical capsaicin for chronic neuropathic pain
Neuropathic pain is associated with disability, reduced quality of life and employment, and increased healthcare costs.
The prevalence of neuropathic pain in the general...
Making sure patients and staff get through this COVID-19 wave
Australia is in the middle of another COVID-19 wave, with case numbers rising sharply since the end of October across the country.
